| ||
| ||
| Tragara Pharmaceuticals' Apricoxib Reverses EMT, a Key Process for Cancer ... PR Newswire (press release) Results from the APRiCOT-L trial, a biomarker-based, phase II, randomized, placebo-controlled study of apricoxib in combination with erlotinib in non-small cell lung cancer, will be presented on June 6th at the ASCO meeting in Chicago. ... See all stories on this topic » | ||
| Back to the Chemo Room Huffington Post (blog) She was 57 and had been battling lung cancer, according to today's Denver Post. Chris was at the chamber for a time while I was at the Post and we developed a professional relationship that now is a pleasant memory. But you don't expect to read about ... See all stories on this topic » | ||
| New Prostate Cancer Treatments Today: Zytiga And The Yunzi Mushroom? Medical News Today ... PSP may benefit patients with advanced non-small cell lung cancer. Other clinical studies using Coriolus extract alone or in combination with other botanicals also suggest positive immunomodulatory effects. However, studies on breast cancer, ... See all stories on this topic » | ||
| Health and Environmental Advocates Applaud Smoke-Free Parks and Beaches ReadMedia (press release) Secondhand smoke contains more than 7000 chemicals, including hundreds that are toxic and at least 69 that cause cancer. It is a proven cause of lung cancer, heart disease, respiratory infections and other serious illnesses. We applaud Mayor Bloomberg, ... See all stories on this topic » | ||
| ||
| McAllen teen dedicates life to anti-smoking advocacy Monitor Rodriguez has also had firsthand experience of its long-term effects as well. Her grandfather died of lung cancer after smoking all his life. "He had been smoking since he was 11 year sold," Rodriguez said. "I know my step dad smoked since he was 10, ... See all stories on this topic » | ||
| Iron Lung Award Leduc Representative "The Iron Lung Award recognizes the City of Leduc for their dedication to innovative, creative and engaging community education about the negative effects of smoking in vehicles and the importance of their new Smoke-Free Vehicles with Minors bylaw ... See all stories on this topic » | ||
| OncoSec Medical to Initiate Multiple Phase II Skin Cancer Clinical Trials PR Newswire (press release) We look forward to these next steps toward our goal of establishing a broad development pipeline for our ElectroImmunotherapy program and improving the quality of life of patients suffering from the life-altering effects of cancer. ... See all stories on this topic » | ||
| US Oncology Research Affiliated Physicians to Present at 2011 ASCO Annual Meeting SYS-CON Media (press release) Robert Jotte, MD, PhD, Rocky Mountain Cancer Centers Tuesday, June 7, 8:00 AM -8:15 AM, Arie Crown Theater Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell -- lung cancer (SCLC). ... See all stories on this topic » | ||
| EULAR 2011 - Vidofludimus Superior to Cyclophosphamide and MMF in an ... Business Wire (press release) In contrast, CYC and MMF had no significant effect on these activity indices. Treatment with vidofludimus also significantly reduced peribronchiolar inflammation, while CYC and MMF failed to achieve any protection of the lung. ... See all stories on this topic » | ||
| Fibershed fashionista Marin Independent-Journal "That's where they're doing the dye work, where they're spinning petroleum threads and the lint is getting into peoples' lungs and creating brown lung and bladder cancer," she said. Burgess will be the first to admit that her fibershed project hasn't ... See all stories on this topic » | ||
| ||
| At-Home Safety: Stay Out of the Sun on "Don't Fry Day" May 27 EHS Today While skin cancer largely is preventable, it remains by far the most common type of cancer in the United States, with over 2 million new cases of diagnosed annually – that's more than new cases of breast, prostate, lung and colon cancers combined. ... See all stories on this topic » | ||
| ||
| Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER ... PR Newswire (press release) "Matching specific markers and gene variations to particular medicines is a more efficient way of developing new anti-cancer agents and more importantly, will enable doctors to make more informed prescribing decisions, reducing risks of side effects ... See all stories on this topic » | ||
|
| ||
| Tragara Pharmaceuticals' Apricoxib Reverses EMT, a Key Process for ... Results from the APRiCOT-L trial, a biomarker-based, phase II, randomized, placebo-controlled study of apricoxib in combination with erlotinib in non-small cell lung cancer, will be presented on June 6th at the ASCO meeting in Chicago. ... colon, and head and neck cancers," stated Francis Burrows, Ph.D., head of oncology biology, Tragara Pharmaceuticals, Inc. "This effect was associated with profound inhibition of metastasis in orthotopic cancer models but, interestingly , ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html |
| ||
| Cisplatin + Taxol Chemotherapy, Side Effects ... - Navigating Cancer What you need to know before starting Cisplatin + Taxol treatment for Non-Small Cell Lung Cancer, how it's given and possible side effects. https://beta.navigatingcancer.com/.../cisplatin-paclitaxel-nsclc | ||
| eduardo - Old people are diagnosed with lung cancer late can live ... Clinically lung cancer late used more traditional Chinese medicine therapy, can obtain good effect. TCM therapy for lung cancer has unique advantages, ... idumuke.livejournal.com/17377.html |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment